Why Doctors Want to Reclassify Psilocybin, the Drug That Puts the ‘Magic’ in Mushrooms

Researchers at Johns Hopkins University hope to eventually reclassify psilocybin from a schedule I to schedule IV drug, according to a news release from the research institution.

View article

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *